PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference

Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) announced its participation in the Lung Cancer Panel at the Cowen 41st Annual Health Care Conference from March 1-4, 2021. David H. Mack, Ph.D., CEO, will speak on March 2 at 11:10 AM. PMV Pharma focuses on developing small molecule, tumor-agnostic therapies targeting p53 mutations, prevalent in about half of all cancers. The company's foundation is rooted in over four decades of p53 biology research by co-founder Dr. Arnold Levine.

Positive

• Participation in a reputable health care conference for visibility and investor engagement.

Negative

• None.

CRANBURY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41^st Annual Health Care Conference taking place virtually on March 1-4, 2021. The company will also participate in one-on-one investor meetings at the conference.

Panel details:

Cowen 41st Annual Health Care Conference Lung Cancer Panel
Date:	Tuesday, March 2, 2021
Time:	11:10am

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.  PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contact

For Investors and Media:

Winston Kung
Chief Financial Officer
investors@pmvpharma.com

Source: PMV Pharmaceuticals, Inc. 

FAQ

When is PMV Pharmaceuticals participating in the Cowen Conference?

PMV Pharmaceuticals will participate in the Cowen 41st Annual Health Care Conference from March 1-4, 2021.

Who will represent PMV Pharmaceuticals at the conference?

David H. Mack, Ph.D., President & CEO, will represent PMV Pharmaceuticals at the conference.

What is the focus of PMV Pharmaceuticals?

PMV Pharmaceuticals specializes in developing therapies targeting p53 mutations, which are found in approximately half of all cancers.

What time will PMV Pharmaceuticals' panel discussion take place?

The Lung Cancer Panel discussion will be held on March 2, 2021, at 11:10 AM.

Where is PMV Pharmaceuticals headquartered?

PMV Pharmaceuticals is headquartered in Cranbury, New Jersey.